rosiglitazone has been researched along with Acute Brain Injuries in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, Y; Ren, S; Wang, L; Wu, G | 1 |
| Alqahtani, F; Cruz-Topete, D; Cucullo, L; Dhaibar, H; Sivandzade, F | 1 |
| Dang, B; Gong, Y; Ji, J; Li, J; Qian, M; Shen, J; Tang, J; Wu, M | 1 |
| Hang, H; Liu, C; Mu, Q; Wang, L; Wu, G | 1 |
| Sullivan, PG; Yonutas, HM | 1 |
| Neuhaus, W; Thal, SC | 1 |
| Jiao, Y; Wang, F; Wang, L; Wu, G; Wu, J; Zhang, Y | 1 |
| Chen, G; Chen, J; Gu, C; Li, J; Wang, Y; Wu, C; Yan, F | 1 |
| Yao, J; Zhang, X; Zheng, K | 1 |
| Culver, S; Dixon, CE; Graham, SH; Liu, H; Ma, X; Rose, ME | 1 |
| Brooks, N; Lang, BT; Park, SW; Vemuganti, R; Yi, JH | 1 |
| Deng, Y; Huang, Y; Li, R; Li, Y; Sun, H; Yang, J; Yu, X; Zhao, G | 1 |
| Hyong, A; Jadhav, V; Lee, S; Rowe, J; Tang, J; Tong, W; Zhang, JH | 1 |
2 review(s) available for rosiglitazone and Acute Brain Injuries
| Article | Year |
|---|---|
Targeting PPAR isoforms following CNS injury.
Topics: Animals; Brain Injuries; Drug Design; Humans; Mitochondrial Proteins; Molecular Targeted Therapy; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Protein Isoforms; Rosiglitazone; Spinal Cord Injuries; Thiazolidinediones | 2013 |
The blood-brain barrier as a target in traumatic brain injury treatment.
Topics: Blood-Brain Barrier; Brain Edema; Brain Injuries; Cell Hypoxia; Humans; Hypoglycemic Agents; Inflammation; Myosin-Light-Chain Kinase; Neurodegenerative Diseases; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptors; Pioglitazone; Receptors, Glucocorticoid; Rosiglitazone; Thiazolidinediones | 2014 |
11 other study(ies) available for rosiglitazone and Acute Brain Injuries
| Article | Year |
|---|---|
PPARĪ³/RAD21 alleviates peripheral secondary brain injury in rat cerebral hemorrhage model through promoting M2 polarization of microglial cells.
Topics: Animals; Brain Injuries; Brain Neoplasms; Cerebral Hemorrhage; Interleukin-10; Microglia; PPAR gamma; Rats; Rosiglitazone; Thrombin; Tumor Necrosis Factor-alpha | 2023 |
Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries.
Topics: Animals; Blood-Brain Barrier; Brain Injuries; Brain Injuries, Traumatic; Hypoglycemic Agents; Male; Metformin; Mice; Mice, Inbred C57BL; Rosiglitazone; Tobacco Smoking | 2023 |
Rosiglitazone inhibits acyl-CoA synthetase long-chain family number 4 and improves secondary brain injury in a rat model of surgical brain injury.
Topics: Animals; Brain; Brain Injuries; Brain Neoplasms; Iron; Ligases; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rosiglitazone; Transferrins | 2023 |
Rosiglitazone pretreatment influences thrombin-induced phagocytosis by rat microglia via activating PPARĪ³ and CD36.
Topics: Animals; Brain Injuries; CD36 Antigens; Cerebral Hemorrhage; Microglia; Neuroprotective Agents; Phagocytosis; PPAR gamma; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Thrombin | 2017 |
Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood-brain barrier disruption in rabbits.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Hematoma; Hypoglycemic Agents; Infusions, Intraventricular; Male; Matrix Metalloproteinase 9; Minimally Invasive Surgical Procedures; Permeability; PPAR gamma; Rabbits; Random Allocation; Rosiglitazone; Thiazolidinediones | 2015 |
Rosiglitazone attenuates early brain injury after experimental subarachnoid hemorrhage in rats.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Caspase 3; Cyclin D1; Disease Models, Animal; In Situ Nick-End Labeling; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Rosiglitazone; Subarachnoid Hemorrhage; Thiazolidinediones | 2015 |
Rosiglitazone exerts neuroprotective effects via the suppression of neuronal autophagy and apoptosis in the cortex following traumatic brain injury.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Brain; Brain Injuries; Caspase 3; Disease Models, Animal; Female; Interleukin-6; Neuroprotective Agents; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats.
Topics: Animals; Anti-Inflammatory Agents; Brain Injuries; Cell Survival; Inflammation; Maze Learning; Neurons; Neuroprotective Agents; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2016 |
PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
Topics: Analysis of Variance; Anilides; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Blotting, Western; Brain Injuries; Cerebral Cortex; Gene Expression; HSP27 Heat-Shock Proteins; Hypoglycemic Agents; In Situ Nick-End Labeling; Injections, Intraperitoneal; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones | 2008 |
Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
Topics: Animals; Benzamides; Blotting, Western; Brain Injuries; CD40 Antigens; Central Nervous System Diseases; Enzyme-Linked Immunosorbent Assay; Epilepsy; Hippocampus; Immunohistochemistry; Inflammation; Lithium Compounds; Male; Pilocarpine; PPAR gamma; Pyridines; Rats; Rats, Sprague-Dawley; Rosiglitazone; Seizures; Status Epilepticus; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2008 |
Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents.
Topics: Analysis of Variance; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Disease Models, Animal; Drug Administration Schedule; Inflammation; Intraoperative Complications; Male; Neuroprotective Agents; Neurosurgical Procedures; Peroxidase; Postoperative Complications; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2008 |